Life Sciences Inc News Today

ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 104,700 shares, a growth of 2,517.5% from the April 30th total of 4,000 shares. Based on an average daily volume of 184,100 […]

SEATTLE and VANCOUVER, British Columbia, May 29, 2024 -- Achieve Life Sciences, Inc. , or Achieve, a late-stage pharmaceutical company committed to the global development and commercialization of...

Increases clarity for ENDRA on regulatory path forward for TAEUS ...

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) – Equities researchers at Zacks Small Cap issued their Q2 2024 earnings per share estimates for shares of Achieve Life Sciences in a note issued to investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten anticipates that the biopharmaceutical company will earn ($0.21) per share […]

Jonestrading assumed coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The firm issued a buy rating and a $20.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ACHV. Lake Street Capital cut their target […]

Jonestrading initiated coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research note released on Wednesday, Benzinga reports. The brokerage issued a buy rating and a $20.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on the company. Oppenheimer restated an […]

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

TriSalus Surpasses Revenue Estimates but Faces Net Loss Wider Than Expected

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.

Operator: Greetings. Welcome to the Achieve Life Sciences Fourth Quarter and Year-End 2023 Earnings Conference Call and Webcast. At this time, all participants are in a listen-only mode.